NCT06067555
Intradermal Influenza Vaccination- Healthy Cohort
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria shortened, about 9 words Show 8 more changesShow less
- Trial completed
- Final enrollment: 42 participants (planned 249)
- Primary completion date changed from estimate of May 2026 to Feb 26, 2025
- Trial arms changed: 9 → 3
- Study description shortened, about 49 words
- Site details revised
- Collaborators revised (4)
- Study title expanded, about 2 words
- Minor Study description expanded, about 3 wordsv6
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jan 2024 to Jan 24, 2024
- Site details revised
- Collaborators: 2 to 4
- Minor Collaborators revised (2)v4
- Notable Eligibility criteria shortened, about 11 words
- Start date: Dec 2023 to Jan 2024
Notable Eligibility criteria expanded, about 58 wordsv2 Show 7 more changesShow less
- Enrollment target: 250 to 249
- Primary and study completion dates: Jan 2026 to May 2026
- Start date: Nov 2023 to Dec 2023
- Interventions: Fluzone® Quadrivalent (Biological), Fluzone® Quadrivalent (Biological), MicronJet (Device) to Bacteriostatic Saline (Other), Fluzone® Quadrivalent (Biological), Fluzone® Quadrivalent (Biological), MicronJet (Device)
- Study description shortened, about 7 words
- Collaborators: 1 to 2
- Study arms: 5 to 9
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change in antibody titer concentration to vaccination-Blood
Timeframe: Day 0 and Day 28
Change in antibody titer concentration to vaccination-Skin
Timeframe: Day 0 and Day 28
Secondary (1)
Change in antibody titer concentration to vaccination
Arms and interventions
Intradermal salinePlacebo comparator
Healthy participants will receive intradermal saline injection.
Intradermal flu vaccineActive comparator
Healthy participants will receive intradermal flu vaccine injection.
Intramuscular fluExperimental
Healthy participants will receive intramuscular flu vaccine injection.
Devices: MicronJet
Biologicals: Fluzone® Quadrivalent
Other: Bacteriostatic Saline
Sites
1 site in 1 country
- Church Street Research UnitNew Haven, Connecticut, United States